Latest Security News

Macquarie Group Limited has announced a quarterly distribution of AUD 1.6148 per MQGPE capital note, payable in September 2026. The payment is partly franked and based on a 3-month BBSW plus a fixed margin, reflecting a 6.41% annualised yield.

WasteCo Group’s Chair Roger Gower will resign in July 2026, with Sean Joyce stepping up as Chair amid ongoing CEO recruitment and operational upgrades.

Charter Hall (ASX: CHC) has announced a 6% increase in its full-year distribution to 50.67 cents per security for FY26, reflecting steady income growth and a fully franked dividend component.

Etherstack's North American arm has landed a US$0.83 million follow-on deal with Codan subsidiary Daniels Electronics, extending a major contract from late 2023. The revenue is expected to be recognised fully in FY26, reinforcing the company’s growth trajectory.

Peel Mining's acquisition by Aeris Resources has cleared its final legal hurdle, with the Supreme Court of NSW approving the scheme of arrangement. Peel shares will suspend trading from 22 June, with implementation slated for 1 July 2026.

Renascor Resources has begun processing graphite through its hydrofluoric acid-free purification flowsheet at its Adelaide demonstration plant, marking a key milestone in its sustainable battery materials strategy.

The court-approved scheme for Pan African Resources to acquire Emmerson Resources has taken effect, leading to Emmerson shares being suspended and shareholders set to receive Pan African CDIs.

Minbos Resources has secured a US$13.8 million Phase 2 construction contract with Grupo Arliz, marking a pivotal step toward completing its Cabinda Phosphate Fertilizer Plant in Angola. With key equipment already on site and funding in place, the project moves closer to operational readiness.

SDI Limited shareholders voted overwhelmingly in favour of a $1.40 per share acquisition scheme by InnoXvest Dental, setting the stage for court approval and delisting.

Critical Minerals Group (ASX: CMG) has secured $1.5 million through a discounted two-tranche placement to accelerate its vanadium electrolyte strategy, including feasibility studies and offtake negotiations.

Recce Pharmaceuticals has secured ethics approval to upgrade and broaden its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, accelerating recruitment and reinforcing its global registration ambitions.

Provaris Energy has raised $1 million through a share placement to fund key 2026 development milestones in hydrogen and liquid CO2 storage, reinforcing its technical progress and partnerships.